Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Change in Receivables (2020 - 2025)

Historic Change in Receivables for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $1.4 million.

  • NeuroPace's Change in Receivables rose 33490.57% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 102943.14%. This contributed to the annual value of $537000.0 for FY2024, which is 8892.78% down from last year.
  • As of Q3 2025, NeuroPace's Change in Receivables stood at $1.4 million, which was up 33490.57% from -$1.9 million recorded in Q2 2025.
  • Over the past 5 years, NeuroPace's Change in Receivables peaked at $2.6 million during Q1 2025, and registered a low of -$1.9 million during Q2 2025.
  • Over the past 5 years, NeuroPace's median Change in Receivables value was $318000.0 (recorded in 2024), while the average stood at $345315.8.
  • Its Change in Receivables has fluctuated over the past 5 years, first soared by 111546.39% in 2022, then tumbled by 38354.76% in 2025.
  • Over the past 5 years, NeuroPace's Change in Receivables (Quarter) stood at $480000.0 in 2021, then plummeted by 181.67% to -$392000.0 in 2022, then soared by 368.37% to $1.1 million in 2023, then rose by 22.62% to $1.3 million in 2024, then grew by 7.21% to $1.4 million in 2025.
  • Its Change in Receivables stands at $1.4 million for Q3 2025, versus -$1.9 million for Q2 2025 and $2.6 million for Q1 2025.